Recon Spine Top Stories Reverse Hip Replacement IDE: A Novel Approach to Total Hip Arthroplasty byTim AllenJuly 6, 2026
Recon Top Stories The Food and Drug Administration Allows Compassionate Use for the Reverse Hip Replacement System byTim AllenMarch 6, 2025
Recon Top Stories Reverse Hip Replacement System Unveiled at Global Orthopedic Surgery Meeting byJosh SandbergFebruary 15, 2024
Recon Hip Innovation Technology Announces Positive Clinical Study Data of its Novel Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty byJosh SandbergJune 28, 2023
Recon Top Stories Total Hip Arthroplasty — New Advance Changes the Game byJosh SandbergFebruary 9, 2023
Recon Top Stories Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study byJosh SandbergJanuary 12, 2023
Recon Hip Innovation Technology Presents Data Demonstrating the Potential Utility of its Novel Hip Replacement System in Addressing Instability Following Total Hip Arthroplasty byChris StewartJuly 20, 2022
Recon Top Stories Hip Innovation Technology Strengthens Senior Leadership Team byChris StewartFebruary 16, 2022
Recon Regulatory Hip Innovation Technology Receives FDA Investigational Device Exemption (IDE) Approval to Initiate Landmark Study of its Reverse Hip Replacement System byJosh SandbergJanuary 19, 2022
Recon Top Stories Hip Innovation Technology Initiates Clinical Trial of its Novel Hip Replacement System for the Treatment of Total Hip Arthroplasty byJosh SandbergAugust 10, 2017
